Facial PalsyNMESNCT06976814
Facial Palsy Treatment
A study testing Neuro muscular electrical stimulation and Beckmann's oral motor exercises in people with Facial Palsy and Stroke Rehabilitation, run by Hamad Medical Corporation at 1 site in Qatar.
Trial summary
The Primary objective of the study is to investigate the most effective treatment modalities available to speech language pathologist as well as movement difference by comparing them. Read more about this study
- Who is it for?
- Ages 20 to 65 years
- Conditions the study is for
- Facial Palsy, Stroke Rehabilitation
- What is being tested?
- Neuro muscular electrical stimulation and Beckmann's oral motor exercises
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteQatar
- Study dates
- 19 Apr 2021to 29 Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients with 1st stroke
- Hemorrhagic stroke
- Ischemic stroke
- Right hemispheric stroke
- Left hemispheric stroke
- Normal cognitive skills (Based on Montreal cognitive assessment MOCA)
- Normal Language (Not Aphasic)
- Normal swallowing
Who cannot join
- Patients with Bell's palsy
- Facial trauma
- Post otitis media surgeries
- Neoplasm, malignant or tumor cell invasion of facial nerve
- Cognitive impairment
- Patients with aphasia
Show all 9Show fewer
- Patients on defibrillator cardiac devices
- Patients with pacemakers or any other type of cardiac devices
- Multiple strokes
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Facial Palsy Treatment: Investigating the Most Effective Modality of Therapy for Recovery?
The Primary objective of the study is to investigate the most effective treatment modalities available to speech language pathologist as well as movement difference by comparing them.
- Conditions
- Facial Palsy, Stroke Rehabilitation
- Being tested
- Neuro muscular electrical stimulation, Beckmann's oral motor exercises
- Medical subject headings
- Facial Paralysis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neuro muscular electrical stimulationOther
electrical stimulation to facial nerve to improve facial palsy
Beckmann's oral motor exercisesOther
Oral motor exercises to improve facial palsy.
| Study group | Role | What they receive |
|---|---|---|
| Neuro muscular electrical stimulation arm | Experimental | Not described Receives: Other: Neuro muscular electrical stimulation |
| Beckmann Oral Motor Exercise Arm | Experimental | Not described Receives: Other: Beckmann's oral motor exercises |
| Neuro Muscular Electrical Stimulation Arm + Beckmann Oral Motor Exercise Arm | Experimental | Not described Receives: Other: Neuro muscular electrical stimulation; Other: Beckmann's oral motor exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sunnybrook Facial Grading System
Upon enrollment Sunnybrook is given as baseline. The minimum score a patient may score is 20 out of 100. The higher the score the better (means patient has minor facial asymmetry). Each participant/patient was planned for 30sessions. Baseline score was recorded and beginning of each week Sunnybrook was given and new score was recorded by the same clinician.
Measured: Patients were enrolled for 30sessions as per the protocol. Participants were given 5 sessions in a week. Patients were assessed as baseline upon enrollment into the study and re-assessed beginning of each week.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 May 2025
- Study start19 Apr 2021
- Primary completion29 Jun 2022
- Study completion29 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Facial PalsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hamad Medical Corporation
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Principal investigator, Mohammed Sajid Hussain, Hamad Medical Corporation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06976814
- Sponsor's protocol ID
- MRC-01-20-1167
- Acronym
- NMES
- Status last verified
- May 2025
- First submitted
- 15 Apr 2025
- Last updated
- 16 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Patient privacy
Study at a glance
From the registry record, last updated by the sponsor on 16 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Facial Palsy Treatment: Investigating the Most Effective Modality of Therapy for Recovery?
- ClinicalTrials.gov ID
- NCT06976814
- Acronym / sponsor ID
- NMES / MRC-01-20-1167
- Conditions
- Facial Palsy, Stroke Rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Hamad Medical CorporationIndustry (pharma, biotech, devices)
- Study start
- 19 Apr 2021 (actual)
- Primary completion
- 29 Jun 2022 (actual)
- Study completion
- 29 Jun 2022 (actual)
- First posted
- 16 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The Primary objective of the study is to investigate the most effective treatment modalities available to speech language pathologist as well as movement difference by comparing them.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Neuro muscular electrical stimulation arm | Experimental | Other: Neuro muscular electrical stimulation |
| Beckmann Oral Motor Exercise Arm | Experimental | Other: Beckmann's oral motor exercises |
| Neuro Muscular Electrical Stimulation Arm + Beckmann Oral Motor Exercise Arm | Experimental | Other: Neuro muscular electrical stimulation, Other: Beckmann's oral motor exercises |
Who may qualify
- Ages
- 20 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Patients with 1st stroke
- Hemorrhagic stroke
- Ischemic stroke
- Right hemispheric stroke
- Left hemispheric stroke
Key exclusion criteria (9 listed)
- Patients with Bell's palsy
- Facial trauma
- Post otitis media surgeries
- Neoplasm, malignant or tumor cell invasion of facial nerve
- Cognitive impairment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neuro muscular electrical stimulationelectrical stimulation to facial nerve to improve facial palsy | Other | Neuro Muscular Electrical Stimulation Arm + Beckmann Oral Motor Exercise Arm, Neuro muscular electrical stimulation arm |
| Beckmann's oral motor exercisesOral motor exercises to improve facial palsy. | Other | Beckmann Oral Motor Exercise Arm, Neuro Muscular Electrical Stimulation Arm + Beckmann Oral Motor Exercise Arm |
Primary outcome
Sunnybrook Facial Grading System
Time frame: Patients were enrolled for 30sessions as per the protocol. Participants were given 5 sessions in a week. Patients were assessed as baseline upon enrollment into the study and re-assessed beginning of each week.
Upon enrollment Sunnybrook is given as baseline. The minimum score a patient may score is 20 out of 100. The higher the score the better (means patient has minor facial asymmetry). Each participant/patient was planned for 30sessions. Baseline score was recorded and beginning of each week Sunnybrook was given and new score was recorded by the same clinician.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 May 2025.
- Individual participant dataSharing planned: No. Patient privacy
Related trials for Facial Palsy
RecruitingPhase 3
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
Vestibular Schwannoma, Facial Nerve Paralysis
Recruiting
Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.
Eye-tracking, Facial Palsy
Recruiting
Treatment for "Asymmetric Crying Facies"
Hemifacial Microsomia, Facial Nerve Paralysis
Recruiting
Combined Effects of Proprioceptive Neuromuscular Facilitation (PNF) and Neural Mobilization on Improving Facial Symmetry in Patients With Bells Palsy
Bell's Palsy, Facial Paralysis
Enrolling by invitationObservational study
Turkish Validation of the Synkinesis Assessment Questionnaire (SAQ)
Facial Paralysis, Facial Palsy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Neuro muscular electrical stimulation and Beckmann's oral motor exercises in people with Facial Palsy and Stroke Rehabilitation, run by Hamad Medical Corporation at 1 site in Qatar.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Qatar. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sunnybrook Facial Grading System (time frame: Patients were enrolled for 30sessions as per the protocol. Participants were given 5 sessions in a week. Patients were assessed as baseline upon enrollment into the study and re-assessed beginning of each week.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025; AzTrials last refreshed its copy on 31 Oct 2026.